Copyright Reports & Markets. All rights reserved.

Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Proprotein Convertase Subtilisin/Kexin Type 9 Market Overview

      • 1.1 Product Overview and Scope of Proprotein Convertase Subtilisin/Kexin Type 9
      • 1.2 Proprotein Convertase Subtilisin/Kexin Type 9 Segment by Type
        • 1.2.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 SX-PCK9
        • 1.2.3 O-304
        • 1.2.4 K-312
        • 1.2.5 BLSM-201
        • 1.2.6 DCRPCSK-9
        • 1.2.7 Others
      • 1.3 Proprotein Convertase Subtilisin/Kexin Type 9 Segment by Application
        • 1.3.1 Proprotein Convertase Subtilisin/Kexin Type 9 Consumption Comparison by Application (2014-2025)
        • 1.3.2 Cardiovascular Disease
        • 1.3.3 Homozugous Familial Hyperchalesterolemia
        • 1.3.4 Liver Disease
        • 1.3.5 Metabolic Syndrome
        • 1.3.6 Others
      • 1.3 Global Proprotein Convertase Subtilisin/Kexin Type 9 Market by Region
        • 1.3.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Size
        • 1.4.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue (2014-2025)
        • 1.4.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Production (2014-2025)

      2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Competition by Manufacturers

      • 2.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Proprotein Convertase Subtilisin/Kexin Type 9 Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites, Area Served, Product Types
      • 2.5 Proprotein Convertase Subtilisin/Kexin Type 9 Market Competitive Situation and Trends
        • 2.5.1 Proprotein Convertase Subtilisin/Kexin Type 9 Market Concentration Rate
        • 2.5.2 Proprotein Convertase Subtilisin/Kexin Type 9 Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Proprotein Convertase Subtilisin/Kexin Type 9 Production Market Share by Regions

      • 3.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Production Market Share by Regions
      • 3.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Proprotein Convertase Subtilisin/Kexin Type 9 Production
        • 3.4.1 North America Proprotein Convertase Subtilisin/Kexin Type 9 Production Growth Rate (2014-2019)
        • 3.4.2 North America Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Proprotein Convertase Subtilisin/Kexin Type 9 Production
        • 3.5.1 Europe Proprotein Convertase Subtilisin/Kexin Type 9 Production Growth Rate (2014-2019)
        • 3.5.2 Europe Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Proprotein Convertase Subtilisin/Kexin Type 9 Production (2014-2019)
        • 3.6.1 China Proprotein Convertase Subtilisin/Kexin Type 9 Production Growth Rate (2014-2019)
        • 3.6.2 China Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Proprotein Convertase Subtilisin/Kexin Type 9 Production (2014-2019)
        • 3.7.1 Japan Proprotein Convertase Subtilisin/Kexin Type 9 Production Growth Rate (2014-2019)
        • 3.7.2 Japan Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Proprotein Convertase Subtilisin/Kexin Type 9 Consumption by Regions

      • 4.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Consumption by Regions
      • 4.2 North America Proprotein Convertase Subtilisin/Kexin Type 9 Consumption (2014-2019)
      • 4.3 Europe Proprotein Convertase Subtilisin/Kexin Type 9 Consumption (2014-2019)
      • 4.4 China Proprotein Convertase Subtilisin/Kexin Type 9 Consumption (2014-2019)
      • 4.5 Japan Proprotein Convertase Subtilisin/Kexin Type 9 Consumption (2014-2019)

      5 Global Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue, Price Trend by Type

      • 5.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Production Market Share by Type (2014-2019)
      • 5.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue Market Share by Type (2014-2019)
      • 5.3 Global Proprotein Convertase Subtilisin/Kexin Type 9 Price by Type (2014-2019)
      • 5.4 Global Proprotein Convertase Subtilisin/Kexin Type 9 Production Growth by Type (2014-2019)

      6 Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Analysis by Applications

      • 6.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Consumption Market Share by Application (2014-2019)
      • 6.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Proprotein Convertase Subtilisin/Kexin Type 9 Business

      • 7.1 AFFiRiS AG
        • 7.1.1 AFFiRiS AG Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
        • 7.1.2 Proprotein Convertase Subtilisin/Kexin Type 9 Product Introduction, Application and Specification
        • 7.1.3 AFFiRiS AG Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Betagenon AB
        • 7.2.1 Betagenon AB Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
        • 7.2.2 Proprotein Convertase Subtilisin/Kexin Type 9 Product Introduction, Application and Specification
        • 7.2.3 Betagenon AB Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Bioleaders Corp
        • 7.3.1 Bioleaders Corp Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
        • 7.3.2 Proprotein Convertase Subtilisin/Kexin Type 9 Product Introduction, Application and Specification
        • 7.3.3 Bioleaders Corp Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 BioLingus AG
        • 7.4.1 BioLingus AG Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
        • 7.4.2 Proprotein Convertase Subtilisin/Kexin Type 9 Product Introduction, Application and Specification
        • 7.4.3 BioLingus AG Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Catabasis Pharmaceuticals Inc
        • 7.5.1 Catabasis Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
        • 7.5.2 Proprotein Convertase Subtilisin/Kexin Type 9 Product Introduction, Application and Specification
        • 7.5.3 Catabasis Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Dicerna Pharmaceuticals Inc
        • 7.6.1 Dicerna Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
        • 7.6.2 Proprotein Convertase Subtilisin/Kexin Type 9 Product Introduction, Application and Specification
        • 7.6.3 Dicerna Pharmaceuticals Inc Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Eli Lilly and Co
        • 7.7.1 Eli Lilly and Co Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
        • 7.7.2 Proprotein Convertase Subtilisin/Kexin Type 9 Product Introduction, Application and Specification
        • 7.7.3 Eli Lilly and Co Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Ensemble Therapeutics Corp
        • 7.8.1 Ensemble Therapeutics Corp Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
        • 7.8.2 Proprotein Convertase Subtilisin/Kexin Type 9 Product Introduction, Application and Specification
        • 7.8.3 Ensemble Therapeutics Corp Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Kowa Co Ltd
        • 7.9.1 Kowa Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
        • 7.9.2 Proprotein Convertase Subtilisin/Kexin Type 9 Product Introduction, Application and Specification
        • 7.9.3 Kowa Co Ltd Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Novartis AG
        • 7.10.1 Novartis AG Proprotein Convertase Subtilisin/Kexin Type 9 Production Sites and Area Served
        • 7.10.2 Proprotein Convertase Subtilisin/Kexin Type 9 Product Introduction, Application and Specification
        • 7.10.3 Novartis AG Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Pfizer Inc
      • 7.12 Regeneron Pharmaceuticals Inc
      • 7.13 Serometrix LLC
      • 7.14 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
      • 7.15 The Medicines Company

      8 Proprotein Convertase Subtilisin/Kexin Type 9 Manufacturing Cost Analysis

      • 8.1 Proprotein Convertase Subtilisin/Kexin Type 9 Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Proprotein Convertase Subtilisin/Kexin Type 9
      • 8.4 Proprotein Convertase Subtilisin/Kexin Type 9 Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Proprotein Convertase Subtilisin/Kexin Type 9 Distributors List
      • 9.3 Proprotein Convertase Subtilisin/Kexin Type 9 Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Proprotein Convertase Subtilisin/Kexin Type 9 Market Forecast

      • 11.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue Forecast
        • 11.1.1 Global Proprotein Convertase Subtilisin/Kexin Type 9 Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Proprotein Convertase Subtilisin/Kexin Type 9 Price and Trend Forecast (2019-2025)
      • 11.2 Global Proprotein Convertase Subtilisin/Kexin Type 9 Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue Forecast (2019-2025)
      • 11.3 Global Proprotein Convertase Subtilisin/Kexin Type 9 Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Proprotein Convertase Subtilisin/Kexin Type 9 Consumption Forecast (2019-2025)
        • 11.3.2 Europe Proprotein Convertase Subtilisin/Kexin Type 9 Consumption Forecast (2019-2025)
        • 11.3.3 China Proprotein Convertase Subtilisin/Kexin Type 9 Consumption Forecast (2019-2025)
        • 11.3.4 Japan Proprotein Convertase Subtilisin/Kexin Type 9 Consumption Forecast (2019-2025)
      • 11.4 Global Proprotein Convertase Subtilisin/Kexin Type 9 Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Proprotein Convertase Subtilisin/Kexin Type 9 Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Proprotein Convertase Subtilisin/Kexin Type 9 market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Proprotein Convertase Subtilisin/Kexin Type 9 volume and value at global level, regional level and company level. From a global perspective, this report represents overall Proprotein Convertase Subtilisin/Kexin Type 9 market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        AFFiRiS AG
        Betagenon AB
        Bioleaders Corp
        BioLingus AG
        Catabasis Pharmaceuticals Inc
        Dicerna Pharmaceuticals Inc
        Eli Lilly and Co
        Ensemble Therapeutics Corp
        Kowa Co Ltd
        Novartis AG
        Pfizer Inc
        Regeneron Pharmaceuticals Inc
        Serometrix LLC
        Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd
        The Medicines Company

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        SX-PCK9
        O-304
        K-312
        BLSM-201
        DCRPCSK-9
        Others

        Segment by Application
        Cardiovascular Disease
        Homozugous Familial Hyperchalesterolemia
        Liver Disease
        Metabolic Syndrome
        Others

        Buy now